These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18568695)

  • 1. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species and glucocorticoid-induced hypertension.
    Ong SL; Zhang Y; Whitworth JA
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):477-82. PubMed ID: 18307745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
    Shen GX
    Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension.
    Mitchell BM; Cook LG; Danchuk S; Puschett JB
    Am J Hypertens; 2007 Dec; 20(12):1297-304. PubMed ID: 18047920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species in hypertension; An update.
    Lassègue B; Griendling KK
    Am J Hypertens; 2004 Sep; 17(9):852-60. PubMed ID: 15363831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells.
    Tumur Z; Niwa T
    Am J Nephrol; 2009; 29(6):551-7. PubMed ID: 19129694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions.
    Czesnikiewicz-Guzik M; Lorkowska B; Zapala J; Czajka M; Szuta M; Loster B; Guzik TJ; Korbut R
    J Physiol Pharmacol; 2008 Mar; 59(1):139-52. PubMed ID: 18441394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and vascular remodelling.
    Fortuño A; San José G; Moreno MU; Díez J; Zalba G
    Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.
    Szasz T; Thakali K; Fink GD; Watts SW
    Exp Biol Med (Maywood); 2007 Jan; 232(1):27-37. PubMed ID: 17202583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and ischemic myocardial syndromes.
    Misra MK; Sarwat M; Bhakuni P; Tuteja R; Tuteja N
    Med Sci Monit; 2009 Oct; 15(10):RA209-219. PubMed ID: 19789524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is oxidative stress a therapeutic target in cardiovascular disease?
    Münzel T; Gori T; Bruno RM; Taddei S
    Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
    Selemidis S
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.